Viewing Study NCT04620200


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2026-01-13 @ 5:36 PM
Study NCT ID: NCT04620200
Status: COMPLETED
Last Update Posted: 2025-08-11
First Post: 2020-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module